hypoglycemia from semaglutide (Ozempic, Wegovy, Rybelsus) Re-imagining Oral Semaglutide in Routine

Comprehensive intake 2

Most concerning long-term effects relate to rapid weight loss rather than the medication directly

Methods We conducted a retrospective cohort study using de-identified electronic health records and performed 1:1 propensity matching on age, sex, type 2 diabetes status, baseline BMI and weight, index year, and follow-up duration

Provide Detailed Information When you speak with your provider, be prepared to share when you took your last dose of Ozempic, what dose you were taking (0.25 mg, 0.5 mg, 1 mg, or 2 mg weekly), how long youve been taking it, approximately when conception likely occurred based on your last menstrual period, and whether youre taking Ozempic for diabetes or weight loss

Rationale MetS is associated with insulin resistance, abdominal obesity, hyperlipidemia, hypertension, platelet hyperactivity, and other CVD risk factors